GRAIL Slides 4.7% as Post-Rally Profit Taking Appears to Offset Recent Bullish Catalysts

GRAIL, Inc. (GRAL) is down 4.7% today. Here is some analysis on what might have caused this price movement.

Analysis: The catalyst is not obvious from today’s company news flow. This could be because investors are taking profits after GRAIL’s sharp late-September rally tied to regulatory momentum for Galleri, while recent insider-sale disclosures and a softer broader market backdrop may also be pressuring shares.

Details:

On September 23, the FDA advisory committee voted that the benefits of GRAIL’s Galleri multi-cancer early detection test outweigh its risks, with unanimous support on safety and a narrower vote on effectiveness.

Earlier that week, FDA briefing materials raised no major new concerns around Galleri, helping fuel a large move higher in the stock before and around the panel meeting.

A Form 4 filed on September 23 showed CEO Joshua Ofman sold shares on September 21 following an option exercise, with the filing stating the transactions were made under a Rule 10b5-1 trading plan.

Separately, a Wall Street firm raised its price target on GRAL to $155 on October 1 while maintaining a Buy rating, which suggests today’s decline does not appear tied to a fresh negative analyst call.

Sources:

GRAIL Investor Relations, SEC, Benzinga

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$GRAL Insider Trading Activity

$GRAL insiders have traded $GRAL stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.

Here’s a breakdown of recent trading of $GRAL stock by insiders over the last 6 months:

JOSHUA J. OFMAN (Chief Executive Officer) has made 0 purchases and 10 sales selling 128,117 shares for an estimated $9,509,645.
ROBERT P RAGUSA (Chief Executive Officer) sold 123,502 shares for an estimated $6,164,923
AARON FREIDIN (Chief Financial Officer) has made 0 purchases and 5 sales selling 57,806 shares for an estimated $3,340,783.
ANDREW JOHN PARTRIDGE (Chief Growth Officer) sold 1,491 shares for an estimated $91,070

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$GRAL Hedge Fund Activity

We have seen 165 institutional investors add shares of $GRAL stock to their portfolio, and 142 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

BLACKROCK, INC. added 608,539 shares (+20.5%) to their portfolio in Q2 2026, for an estimated $41,544,957
ALYESKA INVESTMENT GROUP, L.P. removed 540,456 shares (-83.7%) from their portfolio in Q2 2026, for an estimated $36,896,931
RA CAPITAL MANAGEMENT, L.P. removed 428,266 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $29,237,719
KINGDON CAPITAL MANAGEMENT, L.L.C. added 340,000 shares (+inf%) to their portfolio in Q2 2026, for an estimated $23,211,800
PRIMECAP MANAGEMENT CO/CA/ added 336,334 shares (+18.2%) to their portfolio in Q2 2026, for an estimated $22,961,522
SESSA CAPITAL IM, L.P. added 318,204 shares (+18.5%) to their portfolio in Q2 2026, for an estimated $21,723,787
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 300,628 shares (+inf%) to their portfolio in Q2 2026, for an estimated $20,523,873

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$GRAL Price Targets

Multiple analysts have issued price targets for $GRAL recently. We have seen 4 analysts offer price targets for $GRAL in the last 6 months, with a median target of $59.0.

Here are some recent targets:

Evie Koslosky from Goldman Sachs set a target price of $60.0 on 06/05/2026
David Westenberg from Piper Sandler set a target price of $56.0 on 05/06/2026
Dan Brennan from TD Cowen set a target price of $69.0 on 05/06/2026
Bradley Bowers from Mizuho set a target price of $58.0 on 04/10/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.